Manon De Vries-Brilland
Institut de Cancérologie de l'Ouest(FR)
Publications by Year
Research Areas
Renal cell carcinoma treatment, Cancer Immunotherapy and Biomarkers, Renal and related cancers, Bladder and Urothelial Cancer Treatments, Ferroptosis and cancer prognosis
Most-Cited Works
- → Checkpoint inhibitors in metastatic papillary renal cell carcinoma(2021)28 cited
- → Are immune checkpoint inhibitors a valid option for papillary renal cell carcinoma? A multicentre retrospective study(2020)24 cited
- → Impact of Iron-Deficiency Management on Quality of Life in Patients with Cancer: A Prospective Cohort Study (CAMARA Study)(2022)16 cited
- → Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma(2023)12 cited
- → Successful Treatment of Metastatic Adult Wilms Tumor With Anti-BRAF Treatment: A Case Report and a Brief Review of the Literature(2019)11 cited
- → Activity of Lutetium-177 Prostate-specific Membrane Antigen and Determinants of Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Previously Treated with Cabazitaxel: The PACAP Study(2024)6 cited
- → Are immune checkpoint inhibitors (ICI) a valid option for papillary renal cell carcinoma (pRCC)? A multicenter retrospective study.(2019)6 cited
- → PD-L1 expression and its prognostic value in metastatic papillary renal cell carcinoma: Results from a GETUG multicenter retrospective cohort(2024)6 cited
- → Efficacy and safety of cabozantinib rechallenge in metastatic renal cell carcinoma: A retrospective multicentric study(2023)3 cited
- → Learning to Train and to Explain a Deep Survival Model with Large-Scale Ovarian Cancer Transcriptomic Data(2024)2 cited